JP2016536312A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016536312A5 JP2016536312A5 JP2016527304A JP2016527304A JP2016536312A5 JP 2016536312 A5 JP2016536312 A5 JP 2016536312A5 JP 2016527304 A JP2016527304 A JP 2016527304A JP 2016527304 A JP2016527304 A JP 2016527304A JP 2016536312 A5 JP2016536312 A5 JP 2016536312A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- nanoparticle
- cell
- nanoparticle composition
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020028423A JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361899080P | 2013-11-01 | 2013-11-01 | |
| US61/899,080 | 2013-11-01 | ||
| US201462040242P | 2014-08-21 | 2014-08-21 | |
| US62/040,242 | 2014-08-21 | ||
| PCT/US2014/063545 WO2015066535A1 (en) | 2013-11-01 | 2014-10-31 | Modular particles for immunotherapy |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020028424A Division JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Division JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016536312A JP2016536312A (ja) | 2016-11-24 |
| JP2016536312A5 true JP2016536312A5 (OSRAM) | 2017-10-19 |
| JP6845691B2 JP6845691B2 (ja) | 2021-03-24 |
Family
ID=51999513
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016527304A Active JP6845691B2 (ja) | 2013-11-01 | 2014-10-31 | 免疫療法のための調節粒子 |
| JP2020028424A Withdrawn JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Active JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2022043714A Withdrawn JP2022078345A (ja) | 2013-11-01 | 2022-03-18 | 免疫療法のための調節粒子 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020028424A Withdrawn JP2020075940A (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2020028423A Active JP6929572B2 (ja) | 2013-11-01 | 2020-02-21 | 免疫療法のための調節粒子 |
| JP2022043714A Withdrawn JP2022078345A (ja) | 2013-11-01 | 2022-03-18 | 免疫療法のための調節粒子 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9884026B2 (OSRAM) |
| EP (1) | EP3062779B1 (OSRAM) |
| JP (4) | JP6845691B2 (OSRAM) |
| KR (2) | KR20190126452A (OSRAM) |
| CN (2) | CN105848649B (OSRAM) |
| AU (4) | AU2014342004B2 (OSRAM) |
| CA (2) | CA2929277C (OSRAM) |
| ES (1) | ES2982087T3 (OSRAM) |
| RU (1) | RU2672055C2 (OSRAM) |
| WO (1) | WO2015066535A1 (OSRAM) |
| ZA (1) | ZA201602826B (OSRAM) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007070660A2 (en) | 2005-12-13 | 2007-06-21 | President And Fellows Of Harvard College | Scaffolds for cell transplantation |
| EP3620185A1 (en) | 2010-10-06 | 2020-03-11 | President and Fellows of Harvard College | Injectable, pore-forming hydrogels for materials-based cell therapies |
| US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
| PL2836234T3 (pl) | 2012-04-12 | 2020-02-28 | Yale University | Podłoża do kontrolowanego dostarczania różnych środków farmaceutycznych |
| SI2838515T1 (sl) | 2012-04-16 | 2020-07-31 | President And Fellows Of Harvard College | Mezoporozni sestavki iz silicijevega dioksida za moduliranje imunskih odgovorov |
| EP2841098A4 (en) | 2012-04-23 | 2016-03-02 | Allertein Therapeutics Llc | NANOPARTICLES FOR THE TREATMENT OF ALLERGIES |
| MX375502B (es) | 2013-04-03 | 2025-03-04 | N Fold Llc | Composiciones de nanoparticulas novedosas. |
| AU2014342004B2 (en) | 2013-11-01 | 2017-10-26 | Yale University | Modular particles for immunotherapy |
| US10428331B2 (en) | 2014-01-16 | 2019-10-01 | Musc Foundation For Research Development | Targeted nanocarriers for the administration of immunosuppressive agents |
| WO2015148971A2 (en) | 2014-03-27 | 2015-10-01 | Research Foundation Of The City University Of New York | Method for detecting or treating triple negative breast cancer |
| CN107073090A (zh) | 2014-04-30 | 2017-08-18 | 哈佛学院董事会 | 结合的疫苗装置和杀死癌细胞的方法 |
| HK1247861A1 (zh) | 2015-01-30 | 2018-10-05 | President And Fellows Of Harvard College | 用於癌症治疗的肿瘤周围和肿瘤内部材料 |
| EP3270932B1 (en) | 2015-03-16 | 2024-08-21 | PDX Pharmaceuticals, Inc. | Cross-linked polymer modified nanoparticles |
| CN107708756A (zh) | 2015-04-10 | 2018-02-16 | 哈佛学院院长等 | 免疫细胞捕获装置及其制备和使用方法 |
| US10493030B2 (en) | 2015-05-22 | 2019-12-03 | Aphios Corporation | Combination HIV therapeutic |
| BR112017025422A2 (pt) * | 2015-05-27 | 2018-08-07 | Univ Northwestern | partículas modificadas por carboidrato e formulações particuladas para modular uma resposta imune |
| US10799456B2 (en) | 2015-06-15 | 2020-10-13 | University Of Washington | Multiple drug lipid nanoparticle composition and related methods for extended drug levels in blood and lymph tissue |
| EA037478B1 (ru) | 2015-08-04 | 2021-04-01 | Дьюк Юниверсити | Генетически кодируемые внутренне неупорядоченные полимеры-"невидимки" для доставки и способы их применения |
| US11752213B2 (en) | 2015-12-21 | 2023-09-12 | Duke University | Surfaces having reduced non-specific binding and antigenicity |
| CN115487351A (zh) | 2016-02-06 | 2022-12-20 | 哈佛学院校长同事会 | 重塑造血巢以重建免疫 |
| WO2017144543A1 (en) * | 2016-02-22 | 2017-08-31 | Onxeo | Combination therapies comprising immuno-oncology agents and belinostat |
| EP3422945B1 (en) | 2016-03-01 | 2020-12-09 | North Carolina State University | Enhanced cancer immunotherapy by microneedle patch-assisted delivery |
| WO2017210476A1 (en) | 2016-06-01 | 2017-12-07 | Duke University | Nonfouling biosensors |
| WO2017218533A1 (en) | 2016-06-13 | 2017-12-21 | Torque Therapeutics, Inc. | Methods and compositions for promoting immune cell function |
| JP2019522486A (ja) | 2016-07-13 | 2019-08-15 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 抗原提示細胞模倣足場およびそれを作製および使用するための方法 |
| AU2017305345B2 (en) | 2016-08-02 | 2024-09-05 | President And Fellows Of Harvard College | Biomaterials for modulating immune responses |
| EP3515928A4 (en) | 2016-09-23 | 2020-04-01 | Duke University | UNSTRUCTURED NON-REPITITIVE POLYPEPTIDES WITH LCST BEHAVIOR |
| WO2018132732A1 (en) | 2017-01-12 | 2018-07-19 | Duke University | Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly |
| CA3056802A1 (en) * | 2017-03-16 | 2018-09-20 | Children's Medical Center Corporation | Non-viral, non-cationic nanoparticles and uses thereof |
| EP3595636A4 (en) | 2017-03-16 | 2021-01-13 | Children's Medical Center Corporation | ENGINEERED LIPOSOMES USED AS THERAPEUTIC AGENTS TARGETING CANCER |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| WO2018213320A1 (en) | 2017-05-15 | 2018-11-22 | Duke University | Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents |
| EP3658168A4 (en) | 2017-06-30 | 2021-07-14 | Duke University | ORDER AND DISORDER AS A DESIGN PRINCIPLE FOR STIMULUS SENSITIVE BIOPOLYMER NETWORKS |
| US11524033B2 (en) | 2017-09-05 | 2022-12-13 | Torque Therapeutics, Inc. | Therapeutic protein compositions and methods of making and using the same |
| US12296018B2 (en) | 2018-01-26 | 2025-05-13 | Duke University | Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same |
| GB201804634D0 (en) * | 2018-03-22 | 2018-05-09 | Aqdot Ltd | Emulsion stabiliser |
| US12257308B2 (en) | 2018-04-30 | 2025-03-25 | Duke University | Stimuli-responsive PEG-like polymer-based drug delivery platform |
| AU2019265632A1 (en) * | 2018-05-09 | 2021-01-07 | Yale University | Particles for spatiotemporal release of agents |
| CN112654346B (zh) * | 2018-07-10 | 2024-06-07 | 加利福尼亚大学董事会 | 生物分子包覆颗粒和薄膜及其用途 |
| WO2020014644A1 (en) * | 2018-07-12 | 2020-01-16 | The Regents Of The University Of Michigan | Compositions and methods for metal containing formulations capable of modulating immune response |
| EP3829622A4 (en) | 2018-08-02 | 2022-05-11 | Duke University | DOUBLE AGONIST FUSION PROTEINS |
| WO2020061129A1 (en) | 2018-09-19 | 2020-03-26 | President And Fellows Of Harvard College | Compositions and methods for labeling and modulation of cells in vitro and in vivo |
| WO2020061419A1 (en) * | 2018-09-20 | 2020-03-26 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Targeting moiety-drug grafted immune cell compositions and methods of use |
| US12433959B2 (en) | 2018-10-01 | 2025-10-07 | The Board Of Trustees Of The Leland Stanford Junior University | Injectable hydrogels for controlled release of immunomodulatory compounds |
| WO2020081929A1 (en) * | 2018-10-19 | 2020-04-23 | University Of Rochester | Immune modulators in combination with radiation treatment for advanced pancreatic cancer |
| RU2706427C1 (ru) * | 2018-12-27 | 2019-11-19 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата |
| EP3911361A4 (en) * | 2019-01-18 | 2022-10-12 | University of Georgia Research Foundation, Inc. | SALT NANOPARTICLES, AND COMPOSITIONS AND METHODS OF USE THEREOF |
| US12263252B2 (en) | 2019-06-05 | 2025-04-01 | The Florida International University Board Of Trustees | Biotherapy for viral infections using biopolymer based micro/nanogels |
| US20200383932A1 (en) * | 2019-06-05 | 2020-12-10 | The Florida International University Board Of Trustees | Biotherapy for viral infections using biopolymer based micro/nanogels |
| US11512314B2 (en) | 2019-07-12 | 2022-11-29 | Duke University | Amphiphilic polynucleotides |
| WO2021011496A1 (en) * | 2019-07-12 | 2021-01-21 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| JP2022540652A (ja) | 2019-07-12 | 2022-09-16 | オレゴン ヘルス アンド サイエンス ユニバーシティ | 分裂期キナーゼ阻害剤と免疫チェックポイント阻害剤との同時送達のための治療用構築物 |
| US20220249389A1 (en) * | 2019-07-12 | 2022-08-11 | Oregon Health & Science University | Immunotherapeutic constructs and methods of their use |
| US20220331415A1 (en) * | 2019-09-18 | 2022-10-20 | The Regents Of The University Of California | Immunoactive microparticles and uses thereof |
| WO2021061837A1 (en) | 2019-09-23 | 2021-04-01 | President And Fellows Of Harvard College | Biomaterial-based antigen free vaccine and the use thereof |
| RU2712212C1 (ru) * | 2019-10-28 | 2020-01-27 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" | Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата |
| CN115335041A (zh) * | 2019-12-05 | 2022-11-11 | 西弗吉尼亚大学 | 负载有蛋白质的plga纳米球 |
| WO2021137611A1 (ko) * | 2019-12-30 | 2021-07-08 | (주)테라베스트 | 나노 구조체가 부착된 면역세포 |
| US20230093708A1 (en) * | 2020-03-04 | 2023-03-23 | Duke University | Protein nanoparticle design and application |
| WO2021231942A1 (en) * | 2020-05-15 | 2021-11-18 | The Board Of Trustees Of The Leland Stanford Junior University | Toll-like receptor (tlr) agonist nanoparticles and uses thereof |
| WO2022006011A1 (en) * | 2020-07-01 | 2022-01-06 | Cello Therapeutics, Inc. | Platelet membrane coated nanoparticles and uses thereof |
| CN112451504B (zh) * | 2020-11-09 | 2022-10-18 | 四川大学华西医院 | 一种载EBV-LMP2 mRNA的核-壳纳米粒的制备方法及应用 |
| US11672875B2 (en) | 2021-03-17 | 2023-06-13 | Saint Louis University | Nanoparticle-alginate gels for X-ray imaging of the vasculature |
| KR20230172544A (ko) * | 2021-04-20 | 2023-12-22 | 퍼듀 리서치 파운데이션 | 면역기능적 담체, 사용 방법, 및 항종양 면역요법으로서의 조성물 물질 |
| GB2605996B (en) * | 2021-04-21 | 2024-09-25 | Act Therapeutics Ltd | Enhancement of treatment with immunotherapeutic agents |
| WO2022225203A1 (ko) * | 2021-04-23 | 2022-10-27 | 서울대학교산학협력단 | 대식세포의 활성 조절용 조성물 |
| WO2023113545A1 (ko) * | 2021-12-16 | 2023-06-22 | 주식회사 포투가바이오 | αPD-1를 포함하는 수지상 세포 모방 기능성 나노구조체 및 이의 제조방법 |
| WO2023113550A1 (ko) * | 2021-12-16 | 2023-06-22 | 주식회사 포투가바이오 | 수지상세포 모방 기능성 나노구조체 및 이의 제조방법 |
| NO20221187A1 (en) | 2022-11-04 | 2024-05-06 | Exact Therapeutics As | Method and system for calculating a point estimate of an ultrasound dose |
| WO2024128868A1 (ko) * | 2022-12-15 | 2024-06-20 | 주식회사 포투가바이오 | αPD-1를 포함하는 수지상 세포 모방 기능성 나노구조체 및 이의 제조방법 |
| CN116172980A (zh) * | 2022-12-28 | 2023-05-30 | 上海百心安生物技术股份有限公司 | 一种核壳结构胶束微球及其制备方法和应用 |
| CN117731637A (zh) * | 2023-12-20 | 2024-03-22 | 上海爱莫思生物技术有限公司 | 一种mdp纳米颗粒及其应用 |
| WO2025149619A1 (en) * | 2024-01-12 | 2025-07-17 | Topas Therapeutics Gmbh | Nanoparticles comprising amphiphilic polymers and lipids for the targeted delivery of antigens |
| CN120324344B (zh) * | 2025-04-18 | 2025-10-17 | 广州医科大学附属第一医院横琴医院(横琴粤澳深度合作区中心医院) | 一种肿瘤微环境响应型级联靶向小激活核酸纳米药物的制备方法及其应用 |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5138069A (en) | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| US5210079A (en) | 1988-01-07 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists |
| US5354867A (en) | 1988-12-06 | 1994-10-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
| WO1995015746A1 (en) | 1993-12-10 | 1995-06-15 | The School Of Pharmacy | Liposome delivery systems |
| US7411051B2 (en) | 1997-03-07 | 2008-08-12 | Human Genome Sciences, Inc. | Antibodies to HDPPA04 polypeptide |
| IL149820A0 (en) | 2002-05-23 | 2002-11-10 | Curetech Ltd | Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| DE10161767T1 (de) | 2002-07-03 | 2018-06-07 | Honjo Tasuku | Immunopotenzierende Zusammensetzungen, die einen Anti-PD-L1 Antikörper enthalten |
| US7052694B2 (en) | 2002-07-16 | 2006-05-30 | Mayo Foundation For Medical Education And Research | Dendritic cell potentiation |
| US7985422B2 (en) | 2002-08-05 | 2011-07-26 | Torrent Pharmaceuticals Limited | Dosage form |
| US7785578B2 (en) | 2002-10-11 | 2010-08-31 | Aciont, Inc. | Non-invasive ocular drug delivery |
| EP1576014B1 (en) | 2002-12-23 | 2011-06-29 | Wyeth LLC | Antibodies against pd-1 and uses thereof |
| US20060099203A1 (en) | 2004-11-05 | 2006-05-11 | Pease Larry R | B7-DC binding antibody |
| JP2008512350A (ja) | 2004-07-01 | 2008-04-24 | イェール ユニバーシティ | 標的化され、そして高密度で薬物が負荷されるポリマー性物質 |
| US20070166281A1 (en) | 2004-08-21 | 2007-07-19 | Kosak Kenneth M | Chloroquine coupled antibodies and other proteins with methods for their synthesis |
| EP2161336B2 (en) | 2005-05-09 | 2017-03-29 | ONO Pharmaceutical Co., Ltd. | Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics |
| NZ563263A (en) * | 2005-05-17 | 2010-04-30 | Univ Connecticut | Composition and methods for immunomodulation in an organism |
| NZ590308A (en) | 2005-06-08 | 2012-02-24 | Dana Farber Cancer Inst Inc | Methods and compositions for the treatment of cancer by inhibiting the programmed cell death 1 (pd-1) pathway |
| AU2006265108C1 (en) | 2005-07-01 | 2013-01-17 | E. R. Squibb & Sons, L.L.C. | Human monoclonal antibodies to programmed death ligand 1 (PD-L1) |
| US20070014845A1 (en) | 2005-07-01 | 2007-01-18 | Yuanpeng Zhang | Liposomal delivery vehicle for hydrophobic drugs |
| DE102005039579B4 (de) | 2005-08-19 | 2022-06-30 | Magforce Ag | Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen |
| US20070243184A1 (en) | 2005-11-08 | 2007-10-18 | Steven Fischkoff | Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy |
| US8658608B2 (en) | 2005-11-23 | 2014-02-25 | Yale University | Modified triple-helix forming oligonucleotides for targeted mutagenesis |
| CN101341516A (zh) | 2005-12-20 | 2009-01-07 | 皇家飞利浦电子股份有限公司 | 用于图像数据运动补偿的方法 |
| JP2008053276A (ja) | 2006-08-22 | 2008-03-06 | Nec Electronics Corp | 半導体装置の製造方法 |
| NZ600281A (en) | 2006-12-27 | 2013-03-28 | Harvard College | Compositions and methods for the treatment of infections and tumors |
| US20090004213A1 (en) | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| RU2473331C2 (ru) * | 2007-04-13 | 2013-01-27 | Юниверсити Оф Норс Техас Хэлс Саенс Сентер Эт Форт Ворс | Состав активированных наночастиц plga, загруженных активным средством, для целенаправленной нанотерапии рака |
| US20090028857A1 (en) | 2007-07-23 | 2009-01-29 | Cell Genesys, Inc. | Pd-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof |
| EP2184355A4 (en) | 2007-08-09 | 2011-04-27 | Daiichi Sankyo Co Ltd | WITH A HYDROPHOBIC MOLECULE MODIFIED ANTIBODY |
| EP2224958A2 (en) | 2007-11-30 | 2010-09-08 | Bristol-Myers Squibb Company | Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| WO2010027423A2 (en) | 2008-08-25 | 2010-03-11 | Amplimmune, Inc. | Compositions of pd-1 antagonists and methods of use |
| US8277812B2 (en) * | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
| EP2398466B1 (en) * | 2008-11-24 | 2021-02-17 | Massachusetts Institute of Technology | Methods and compositions for localized nanoparticle delivery to a tumor |
| WO2010083337A2 (en) | 2009-01-15 | 2010-07-22 | The Regents Of The University Of Califorinia | Composite nanostructures and methods for making and using them |
| AU2010312078B2 (en) | 2009-10-26 | 2015-10-08 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt |
| WO2011133803A1 (en) | 2010-04-21 | 2011-10-27 | Helix Therapeutics, Inc. | Compositions and methods for targeted inactivation of hiv cell surface receptors |
| US20110293690A1 (en) | 2010-05-27 | 2011-12-01 | Tyco Healthcare Group Lp | Biodegradable Polymer Encapsulated Microsphere Particulate Film and Method of Making Thereof |
| AU2011279024A1 (en) | 2010-07-16 | 2013-02-21 | The Johns Hopkins University | Methods and compositions for cancer immunotherapy |
| EP2640359A4 (en) * | 2010-11-18 | 2015-11-04 | Gen Hospital Corp | NOVEL COMPOSITIONS AND USES OF HYPOTENSE AGENTS IN THE TREATMENT OF CANCER |
| BR112013028570A2 (pt) * | 2011-05-09 | 2019-09-24 | Institut Quim De Sarria | nanopartículas poliméricas para administração de fármacos |
| PL2836234T3 (pl) | 2012-04-12 | 2020-02-28 | Yale University | Podłoża do kontrolowanego dostarczania różnych środków farmaceutycznych |
| AU2014342004B2 (en) | 2013-11-01 | 2017-10-26 | Yale University | Modular particles for immunotherapy |
-
2014
- 2014-10-31 AU AU2014342004A patent/AU2014342004B2/en active Active
- 2014-10-31 ES ES14805404T patent/ES2982087T3/es active Active
- 2014-10-31 US US15/034,106 patent/US9884026B2/en active Active
- 2014-10-31 EP EP14805404.2A patent/EP3062779B1/en active Active
- 2014-10-31 CA CA2929277A patent/CA2929277C/en active Active
- 2014-10-31 KR KR1020197032420A patent/KR20190126452A/ko not_active Ceased
- 2014-10-31 RU RU2016121422A patent/RU2672055C2/ru active
- 2014-10-31 CN CN201480070407.XA patent/CN105848649B/zh active Active
- 2014-10-31 JP JP2016527304A patent/JP6845691B2/ja active Active
- 2014-10-31 CA CA2987519A patent/CA2987519A1/en not_active Abandoned
- 2014-10-31 WO PCT/US2014/063545 patent/WO2015066535A1/en not_active Ceased
- 2014-10-31 CN CN201910629569.7A patent/CN110302162A/zh active Pending
- 2014-10-31 KR KR1020167014652A patent/KR102460800B1/ko active Active
-
2016
- 2016-04-25 ZA ZA201602826A patent/ZA201602826B/en unknown
-
2017
- 2017-12-07 AU AU2017272274A patent/AU2017272274A1/en not_active Abandoned
-
2018
- 2018-01-03 US US15/860,888 patent/US10751291B2/en active Active
-
2019
- 2019-10-09 AU AU2019246802A patent/AU2019246802B2/en active Active
-
2020
- 2020-02-21 JP JP2020028424A patent/JP2020075940A/ja not_active Withdrawn
- 2020-02-21 JP JP2020028423A patent/JP6929572B2/ja active Active
- 2020-08-06 US US16/986,393 patent/US20210015758A1/en not_active Abandoned
-
2021
- 2021-08-26 AU AU2021221886A patent/AU2021221886A1/en not_active Abandoned
-
2022
- 2022-03-18 JP JP2022043714A patent/JP2022078345A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016536312A5 (OSRAM) | ||
| RU2016121422A (ru) | Модульные частицы для иммунотерапии | |
| Phuengkham et al. | A designer scaffold with immune nanoconverters for reverting immunosuppression and enhancing immune checkpoint blockade therapy | |
| Bauleth‐Ramos et al. | Acetalated dextran nanoparticles loaded into an injectable alginate cryogel for combined chemotherapy and cancer vaccination | |
| Ban et al. | Emerging systemic delivery strategies of oncolytic viruses: a key step toward cancer immunotherapy | |
| Simpson et al. | Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances | |
| Xu et al. | Prevention of colorectal cancer liver metastasis by exploiting liver immunity via chitosan-TPP/nanoparticles formulated with IL-12 | |
| Luo et al. | Nanocarrier co-formulation for delivery of a TLR7 agonist plus an immunogenic cell death stimulus triggers effective pancreatic cancer chemo-immunotherapy | |
| JP2019534308A5 (OSRAM) | ||
| Ramakrishnan et al. | Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer | |
| Torres Andon et al. | Nanomedicine and cancer immunotherapy–targeting immunosuppressive cells | |
| WO2016018920A8 (en) | Il-15 and il-15ralpha heterodimer dose escalation regimens for treating conditions | |
| JP2019532080A5 (OSRAM) | ||
| WO2016004048A3 (en) | Targeted conjugates and particles and formulations thereof | |
| EP2620157A3 (en) | Vaccine nanotechnology | |
| NZ593343A (en) | Combination cancer treatment conprising Abraxane and an inflamatory inhibitor | |
| García et al. | Self-assembled nanomaterials | |
| EP3064220A3 (en) | Compositions and methods for the treatment of infections and tumors | |
| WO2010063011A3 (en) | Methods for the treatment of infections and tumors | |
| JP2016513953A5 (OSRAM) | ||
| JP7570134B2 (ja) | 治療用ワクチンとしての使用のためのナノ粒子 | |
| WO2015153805A3 (en) | Targeted polymerized nanoparticles for cancer treatment | |
| Seo et al. | Short review on advances in hydrogel-based drug delivery strategies for cancer immunotherapy | |
| Lee et al. | Poly d, l-lactide-co-glycolide (PLGA) nanoparticle-encapsulated honeybee (Apis melifera) venom promotes clearance of Salmonella enterica serovar Typhimurium infection in experimentally challenged pigs through the up-regulation of T helper type 1 specific immune responses | |
| CN106237340B (zh) | 透明质酸纳米颗粒在制备治疗淋巴系统肿瘤的药物的用途 |